Changes in the monitoring and management of hypertension during the COVID-19 pandemic

Satish Munigala; Christian L. Coles; Vivitha Mani; Amanda Banaag; Sarah Selica Miura; Andrew J. Schoenfeld; Tracey Perez Koehlmoos

doi:10.1186/s12889-025-25761-y

December 2, 2025BMC Public HealthOpen Access

Changes in the monitoring and management of hypertension during the COVID-19 pandemic

View Full Paper

Ask AI

Bookmark

Share

Key Points

Diagnosis of hypertension significantly reduced during the COVID-19 period, impacting patient care.
BP control decreased alongside reduced follow-up health care visits, indicating care gaps.
Assessment focused on the management of hypertension and its changes during COVID-19.
The findings highlight potential issues in hypertension management during public health crises.

Abstract

We found a significant reduction in the diagnosis of hypertension among beneficiaries during the COVID-19 period. BP control decreased in parallel during the period of COVID-19, with a corresponding reduction in follow-up health care visits among individuals with uncontrolled hypertension.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Munigala et al. (2025) studied this question.

synapsesocial.com/papers/69337cdbb3f947a0a1259f06 https://doi.org/10.1186/s12889-025-25761-y

View Full Paper

Ask AI

Bookmark

Share

Changes in the monitoring and management of hypertension during the COVID-19 pandemic

Key Points

Abstract

Discussion

Cite This Study

Changes in the monitoring and management of hypertension during the COVID-19 pandemic

Key Points

Abstract

Discussion

Cite This Study

Keep reading

More related papers

More from BMC Public Health

Keep reading

More related papers

More from BMC Public Health